167 related articles for article (PubMed ID: 29331658)
1. Sulforaphene Enhances The Efficacy of Photodynamic Therapy In Anaplastic Thyroid Cancer Through Ras/RAF/MEK/ERK Pathway Suppression.
Chatterjee S; Rhee Y; Chung PS; Ge RF; Ahn JC
J Photochem Photobiol B; 2018 Feb; 179():46-53. PubMed ID: 29331658
[TBL] [Abstract][Full Text] [Related]
2. Combination with genistein enhances the efficacy of photodynamic therapy against human anaplastic thyroid cancer cells.
Ahn JC; Biswas R; Chung PS
Lasers Surg Med; 2012 Dec; 44(10):840-9. PubMed ID: 23143780
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells.
Biswas R; Chung PS; Moon JH; Lee SH; Ahn JC
Lasers Med Sci; 2014 May; 29(3):995-1007. PubMed ID: 24114422
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of synergistic effects of sulforaphene with photodynamic therapy in human cervical cancer cell line.
Biswas R; Mondal A; Chatterjee S; Ahn JC
Lasers Med Sci; 2016 Nov; 31(8):1675-1682. PubMed ID: 27485253
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of EGFR/PI3K and activation of PTEN by photodynamic therapy combined with carboplatin in human anaplastic thyroid cancer cells and xenograft tumors in nude mice.
Biswas R; Mondal A; Ahn JC
J Photochem Photobiol B; 2015 Jul; 148():118-127. PubMed ID: 25910816
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphene-Carboplatin Combination Synergistically Enhances Apoptosis by Disruption of Mitochondrial Membrane Potential and Cell Cycle Arrest in Human Non-Small Cell Lung Carcinoma.
Chatterjee S; Rhee YH; Ahn JC
J Med Food; 2016 Sep; 19(9):860-9. PubMed ID: 27467015
[TBL] [Abstract][Full Text] [Related]
8. Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma.
Milosevic Z; Pesic M; Stankovic T; Dinic J; Milovanovic Z; Stojsic J; Dzodic R; Tanic N; Bankovic J
Transl Res; 2014 Nov; 164(5):411-23. PubMed ID: 25016932
[TBL] [Abstract][Full Text] [Related]
9. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
Tong Z; Singh G; Rainbow AJ
Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
[TBL] [Abstract][Full Text] [Related]
11. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
12. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.
Cohen SM; Mukerji R; Timmermann BN; Samadi AK; Cohen MS
Am J Surg; 2012 Dec; 204(6):895-900; discussion 900-1. PubMed ID: 23231932
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphene Synergistically Sensitizes Cisplatin via Enhanced Mitochondrial Dysfunction and PI3K/PTEN Modulation in Ovarian Cancer Cells.
Biswas R; Ahn JC; Kim JS
Anticancer Res; 2015 Jul; 35(7):3901-8. PubMed ID: 26124336
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphene suppresses growth of colon cancer-derived tumors via induction of glutathione depletion and microtubule depolymerization.
Byun S; Shin SH; Park J; Lim S; Lee E; Lee C; Sung D; Farrand L; Lee SR; Kim KH; Dong Z; Lee SW; Lee KW
Mol Nutr Food Res; 2016 May; 60(5):1068-78. PubMed ID: 26918318
[TBL] [Abstract][Full Text] [Related]
16. Methylene blue-mediated photodynamic therapy enhances apoptosis in lung cancer cells.
Lim EJ; Oak CH; Heo J; Kim YH
Oncol Rep; 2013 Aug; 30(2):856-62. PubMed ID: 23708127
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
[TBL] [Abstract][Full Text] [Related]
18. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
19. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway.
Wang L; Tian Z; Yang Q; Li H; Guan H; Shi B; Hou P; Ji M
Oncotarget; 2015 Sep; 6(28):25917-31. PubMed ID: 26312762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
